In this review:
Drug-level guided adalimumab dosing is cost effective
The significance of RNP ab-positivity in diagnosis of SARD
Oral bisphosphonates: not useful in knee OA
. . . and do not appear to change BMLs
Significant BMD loss after bariatric surgery
Management of PAH in systemic sclerosis
Upadacitinib shows efficacy in csDMARD-IR RA
A positive MRI-SI not specific for axSpA
Bimekizumab blocks osteogenic differentiation
New guidelines on HCQ dosage
“Fibromyalgia-ness” in osteoarthritis
Please login below to download this issue (PDF)